Novel ankyrin repeat domain-containing protein pseudogene

The **Novel ankyrin repeat domain-containing protein pseudogene** (ENSG00000279924) is classified as a human pseudogene, meaning it is a genomic sequence that resembles a protein-coding gene but contains mutations or structural changes that prevent it from producing a functional protein[1][2]. Pseudogenes can arise via several mechanisms, such as gene duplication or retrotransposition, but are usually considered nonfunctional in terms of protein coding[2][4]. However, increasing evidence shows that some pseudogenes may exert regulatory functions at the RNA level, such as acting as decoys for microRNAs, antisense RNAs, or contributing to gene expression regulation in specific contexts[3][4][5]. Although a small number of pseudogenes have been implicated in disease biology or as regulatory elements (for instance, PTENP1 or KRASP1), there is no evidence that ENSG00000279924 is associated with disease, therapeutic drug targeting, or function as a biomarker or safety concern[1]. This pseudogene is not classified as a receptor, enzyme, transporter, or similar molecular target, nor does it have any known interacting drugs or mechanism of action relevant to pharmacology[1]. As a pseudogene, it is not considered a therapeutic target. **Reason for 'is_incorrect: true':** The entry refers to a pseudogene, which is not considered a functional protein target, receptor, enzyme, or direct therapeutic target. Therefore, it is not suitable for inclusion in structured databases of druggable targets or receptor classifications[1][4].